Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Influenza

Free Subscription Articles published in Antiviral Res Retrieve available abstracts of 37 articles: HTML format

Single Articles

June 2008
1. WANG R , Song A, Levin J, Dennis D, et al
   Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. BOLTZ DA , Ilyushina NA, Arnold CS, Babu YS, et al
   Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. HOFFMANN HH , Palese P, Shaw ML
   Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
4. BASLER CF , Aguilar PV
   Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. AO Z , Patel A, Tran K, He X, et al
   Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
6. GILBERT BE , McLeay MT
   MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. BEIGEL J , Bray M
   Current and future antiviral therapy of severe seasonal and avian influenza.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
8. NAKAZAWA M , Kadowaki SE, Watanabe I, Kadowaki Y, et al
   PA subunit of RNA polymerase as a promising target for anti-influenza virus agents.
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. PABBARAJU K , Ho KC, Wong S, Shokoples S, et al
   Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
   Antiviral Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
10. HIGGS ES , Hayden FG, Chotpitayasunondh T, Whitworth J, et al
    The Southeast Asian Influenza Clinical Research Network: Development and challenges for a new multilateral research endeavor.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
11. MAO H , Thakur CS, Chattopadhyay S, Silverman RH, et al
    Inhibition of human parainfluenza virus type 3 infection by novel small molecules.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
12. HE G , Qiao J, Dong C, He C, et al
    Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. ABED Y , Nehme B, Baz M, Boivin G, et al
    Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
14. HO HT , Hurt AC, Mosse J, Barr I, et al
    Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. ZHOU H , Jin M, Yu Z, Xu X, et al
    Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. SONG JM , Park KD, Lee KH, Byun YH, et al
    Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
17. EHRHARDT C , Hrincius ER, Korte V, Mazur I, et al
    A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
18. DROEBNER K , Ehrhardt C, Poetter A, Ludwig S, et al
    CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
19. JIANG Y , Yu K, Zhang H, Zhang P, et al
    Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. BAUER K , Schrader C, Suess J, Wutzler P, et al
    Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
21. BARR IG , Hurt AC, Deed N, Iannello P, et al
    The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
22. HAYASHI K , Imanishi N, Kashiwayama Y, Kawano A, et al
    Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
23. BAZ M , Abed Y, Boivin G
    Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
24. HURT AC , Selleck P, Komadina N, Shaw R, et al
    Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
25. SIDWELL RW , Barnard DL
    Respiratory syncytial virus infections: recent prospects for control.
    Antiviral Res. 2006;71.
    PubMed     Related articles    Abstract available
    
    
    
26. PATICK AK
    Rhinovirus chemotherapy.
    Antiviral Res. 2006;71.
    PubMed     Related articles    Abstract available
    
    
    August 2006
27. BARR IG , Hurt AC, Iannello P, Tomasov C, et al
    Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
28. HAMMERBECK DM , Burleson GR, Schuller CJ, Vasilakos JP, et al
    Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
29. XIE YY , Zhao XD, Jiang LP, Liu HL, et al
    Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme).
    Antiviral Res. 2006;71:31-41.
    PubMed     Related articles    Abstract available
    
    
    July 2006
30. NOAH JW , Severson W, Noah DL, Rasmussen L, et al
    A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
31. HAYDEN FG
    Antivirals for influenza: Historical perspectives and lessons learned.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    May 2006
32. TANAKA Y , Kato J, Kohara M, Galinski MS, et al
    Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
33. MISHIN VP , Hayden FG, Signorelli KL, Gubareva LV, et al
    Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
34. GUO CT , Takahashi T, Bukawa W, Takahashi N, et al
    Edible bird's nest extract inhibits influenza virus infection.
    Antiviral Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    February 2006
35. BONVILLE CA , Rosenberg HF, Domachowske JB
    Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.
    Antiviral Res. 2006;69:53-9.
    PubMed     Related articles    Abstract available
    
    
    December 2005
36. OJWANG JO , Wang YH, Wyde PR, Fischer NH, et al
    A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
    Antiviral Res. 2005;68:163-72.
    PubMed     Related articles    Abstract available
    
    
    
37. LEDFORD RM , Collett MS, Pevear DC
    Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
    Antiviral Res. 2005;68:135-8.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

This E-mail is provided by AMEDEO through an unrestricted educational grant from www.InfluenzaWorld.com, a Roche service.

Amedeo is a Bernd Sebastian Kamps website.    Design: